285 Glioblastoma Clinical Trials Recruiting Now (September 2026): GBM, MGMT, TTFields, GammaTile, CAR-T
Standard of care (Stupp protocol, since 2005): Maximal safe resection → concurrent radiation + temozolomide → adjuvant temozolomide.
Clinical trials are critical for patients with glioblastoma, especially for those with MGMT‑unmethylated tumors where standard temozolomide has limited benefit. New studies, such as those adding tumor treating fields (TTFields) or novel systemic agents, offer potential improvements in overall survival and symptom control.
Bizonyítékszint: Sejtvonalas. Laboratóriumi sejtekben vizsgálták.
Kapcsolódó jelek
- Glioma
- Glioblastoma Clinical Trials for New Treatments
- Clinical trial links oncolytic immunoactivation to survival in glioblastoma
- Treating the invisible target: treatment planning targeting the microscopic tumor spread in gliomas
- EGFR inhibition down-regulates MGMT and enhances responsiveness to temozolomide in glioblastoma